Clinical Trial Update: Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients [NA]

View source ↗

Summary

Clinical trial update on reduced-intensity therapy for oropharyngeal cancer in non-smoking HPV-16 positive patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Squamous Cell Carcinoma of the Oropharynx, HPV | NA | Status: COMPLETED | Results posted: 2020-10-26